메뉴 건너뛰기




Volumn 31, Issue 9, 2011, Pages 1856-1862

Intravitreal bevacizumab for macular edema secondary to branch retinal vein occlusion

Author keywords

avastin; bevacizumab; branch retinal vein occlusion; BRVO; macular edema

Indexed keywords

BEVACIZUMAB;

EID: 80053376308     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e31820d59a5     Document Type: Article
Times cited : (36)

References (27)
  • 1
    • 0021221946 scopus 로고
    • Argon laser photocoagulation for macular edema in branch vein occlusion
    • The Branch Vein Occlusion Study Group
    • Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group. Am J Ophthalmol 1984;98:271-282.
    • (1984) Am J Ophthalmol , vol.98 , pp. 271-282
  • 2
    • 40449116718 scopus 로고    scopus 로고
    • Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation
    • Cakir M, Dogan M, Bayraktar Z, et al. Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation. Retina 2008;28:465-472.
    • (2008) Retina , vol.28 , pp. 465-472
    • Cakir, M.1    Dogan, M.2    Bayraktar, Z.3
  • 3
    • 33745782355 scopus 로고    scopus 로고
    • Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration
    • Rich RM, Rosenfeld PJ, Puliafito CA, et al. Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Retina 2006;26: 495-511.
    • (2006) Retina , vol.26 , pp. 495-511
    • Rich, R.M.1    Rosenfeld, P.J.2    Puliafito, C.A.3
  • 4
    • 77952891051 scopus 로고    scopus 로고
    • Ranibizumab for macular edema following branch retinal vein occlusion: Sixmonth primary end point results of a phase III study
    • Campochiaro PA, Heier JS, Feiner L, et al. Ranibizumab for macular edema following branch retinal vein occlusion: Sixmonth primary end point results of a phase III study. Ophthalmology 2010;117:1102-1112.e1.
    • (2010) Ophthalmology , vol.117
    • Campochiaro, P.A.1    Heier, J.S.2    Feiner, L.3
  • 5
    • 70349247768 scopus 로고    scopus 로고
    • A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6
    • Scott IU, Ip MS, VanVeldhuisen PC, et al. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6. Arch Ophthalmol 2009;127:1115-1128.
    • (2009) Arch Ophthalmol , vol.127 , pp. 1115-1128
    • Scott, I.U.1    Ip, M.S.2    VanVeldhuisen, P.C.3
  • 6
    • 65549105567 scopus 로고    scopus 로고
    • Retinal gene expression and Muller cell responses after branch retinal vein occlusion in the rat
    • Rehak M, Hollborn M, Iandiev I, et al. Retinal gene expression and Muller cell responses after branch retinal vein occlusion in the rat. Invest Ophthalmol Vis Sci 2009;50:2359-2367.
    • (2009) Invest Ophthalmol Vis Sci , vol.50 , pp. 2359-2367
    • Rehak, M.1    Hollborn, M.2    Iandiev, I.3
  • 7
    • 38349179299 scopus 로고    scopus 로고
    • Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion
    • Noma H, Funatsu H, Yamasaki M, et al. Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion. Eye (Lond) 2008;22:42-48.
    • (2008) Eye (Lond , vol.22 , pp. 42-48
    • Noma, H.1    Funatsu, H.2    Yamasaki, M.3
  • 8
    • 72049090107 scopus 로고    scopus 로고
    • Pegaptanib sodium for macular edema secondary to branch retinal vein occlusion
    • Wroblewski JJ,Wells JA 3rd, Gonzales CR. Pegaptanib sodium for macular edema secondary to branch retinal vein occlusion. Am J Ophthalmol 2010;149:147-154.
    • (2010) Am J Ophthalmol , vol.149 , pp. 147-154
    • Wroblewski, J.J.1    Wells III, J.A.2    Gonzales, C.R.3
  • 9
    • 23044505200 scopus 로고    scopus 로고
    • Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration
    • Rosenfeld PJ, Moshfeghi AA, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging 2005;36:331-335.
    • (2005) Ophthalmic Surg Lasers Imaging , vol.36 , pp. 331-335
    • Rosenfeld, P.J.1    Moshfeghi, A.A.2    Puliafito, C.A.3
  • 10
    • 33745091547 scopus 로고    scopus 로고
    • Intravitreal bevacizumab treatment of choroidal neovascularization secondary to agerelated macular degeneration
    • Spaide RF, Laud K, Fine HF, et al. Intravitreal bevacizumab treatment of choroidal neovascularization secondary to agerelated macular degeneration. Retina 2006;26:383-390.
    • (2006) Retina , vol.26 , pp. 383-390
    • Spaide, R.F.1    Laud, K.2    Fine, H.F.3
  • 11
    • 0022645069 scopus 로고
    • Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial. branch vein occlusion study group
    • Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial. Branch Vein Occlusion Study Group. Arch Ophthalmol 1986;104:34-41.
    • (1986) Arch Ophthalmol , vol.104 , pp. 34-41
  • 12
    • 67651155889 scopus 로고    scopus 로고
    • Changes of aqueous vascular endothelial growth factor and pigment epithelium-derived factor following intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion
    • Park SP, Ahn JK. Changes of aqueous vascular endothelial growth factor and pigment epithelium-derived factor following intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion. Clin Experiment Ophthalmol 2009;37:490-495.
    • (2009) Clin Experiment Ophthalmol , vol.37 , pp. 490-495
    • Park, S.P.1    Ahn, J.K.2
  • 14
    • 41849095644 scopus 로고    scopus 로고
    • Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: A prospective study
    • Kriechbaum K, Michels S, Prager F, et al. Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: A prospective study. Br J Ophthalmol 2008;92:518-522.
    • (2008) Br J Ophthalmol , vol.92 , pp. 518-522
    • Kriechbaum, K.1    Michels, S.2    Prager, F.3
  • 15
    • 34247231034 scopus 로고    scopus 로고
    • Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion
    • Rabena MD, Pieramici DJ, Castellarin AA, Nasir MA, Avery RL. Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion. Retina 2007;27:419-425.
    • (2007) Retina , vol.27 , pp. 419-425
    • Rabena, M.D.1    Pieramici, D.J.2    Castellarin, A.A.3    Nasir, M.A.4    Avery, R.L.5
  • 16
    • 40549120630 scopus 로고    scopus 로고
    • Intravitreal bevacizumab for the treatment of macular oedema secondary to branch retinal vein occlusion
    • Kreutzer TC, Alge CS, Wolf AH, et al. Intravitreal bevacizumab for the treatment of macular oedema secondary to branch retinal vein occlusion. Br J Ophthalmol 2008;92: 351-355.
    • (2008) Br J Ophthalmol , vol.92 , pp. 351-355
    • Kreutzer, T.C.1    Alge, C.S.2    Wolf, A.H.3
  • 19
    • 33947401512 scopus 로고    scopus 로고
    • Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion
    • Pai SA, Shetty R, Vijayan PB, et al. Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion. Am J Ophthalmol 2007;143:601-606.
    • (2007) Am J Ophthalmol , vol.143 , pp. 601-606
    • Pai, S.A.1    Shetty, R.2    Vijayan, P.B.3
  • 20
    • 68249096210 scopus 로고    scopus 로고
    • Safety and efficacy of intravitreal bevacizumab (avastin) for the management of branch and hemiretinal vein occlusion
    • Gregori NZ, Rattan GH, Rosenfeld PJ, et al. Safety and efficacy of intravitreal bevacizumab (avastin) for the management of branch and hemiretinal vein occlusion. Retina 2009; 29:913-925.
    • (2009) Retina , vol.29 , pp. 913-925
    • Gregori, N.Z.1    Rattan, G.H.2    Rosenfeld, P.J.3
  • 21
    • 71449106064 scopus 로고    scopus 로고
    • Longterm follow-up of OCT-guided bevacizumab treatment of macular edema due to retinal vein occlusion
    • Hoeh AE, Ach T, Schaal KB, Scheuerle AF, Dithmar S. Longterm follow-up of OCT-guided bevacizumab treatment of macular edema due to retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2009;247:1635-1641.
    • (2009) Graefes Arch Clin Exp Ophthalmol , vol.247 , pp. 1635-1641
    • Hoeh, A.E.1    Ach, T.2    Schaal, K.B.3    Scheuerle, A.F.4    Dithmar, S.5
  • 22
    • 64849111444 scopus 로고    scopus 로고
    • Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial
    • Prager F, Michels S, Kriechbaum K, et al. Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial. Br J Ophthalmol 2009;93:452-456.
    • (2009) Br J Ophthalmol , vol.93 , pp. 452-456
    • Prager, F.1    Michels, S.2    Kriechbaum, K.3
  • 23
    • 42449094689 scopus 로고    scopus 로고
    • Comparison of two doses of intravitreal bevacizumab (Avastin) for treatment of macular edema secondary to branch retinal vein occlusion: Results from the Pan-American Collaborative Retina Study Group at 6 months of follow-up
    • Wu L, Arevalo JF, Roca JA, et al. Comparison of two doses of intravitreal bevacizumab (Avastin) for treatment of macular edema secondary to branch retinal vein occlusion: Results from the Pan-American Collaborative Retina Study Group at 6 months of follow-up. Retina 2008;28:212-219.
    • (2008) Retina , vol.28 , pp. 212-219
    • Wu, L.1    Arevalo, J.F.2    Roca, J.A.3
  • 24
    • 57649094780 scopus 로고    scopus 로고
    • Early intravitreal bevacizumab for non-ischaemic branch retinal vein occlusion
    • Rensch F, Jonas JB, Spandau UH. Early intravitreal bevacizumab for non-ischaemic branch retinal vein occlusion. Ophthalmologica 2009;223:124-127.
    • (2009) Ophthalmologica , vol.223 , pp. 124-127
    • Rensch, F.1    Jonas, J.B.2    Spandau, U.H.3
  • 25
    • 77951240776 scopus 로고    scopus 로고
    • Comparison of bevacizumab and triamcinolone for treatment of macular edema secondary to branch retinal vein occlusion in a pairmatched analysis
    • Guthoff R, Meigen T, Hennemann K, SchraderW. Comparison of bevacizumab and triamcinolone for treatment of macular edema secondary to branch retinal vein occlusion in a pairmatched analysis. Ophthalmologica 2010;224:319-324.
    • (2010) Ophthalmologica , vol.224 , pp. 319-324
    • Guthoff, R.1    Meigen, T.2    Hennemann, K.3    Schrader, W.4
  • 26
    • 77955654660 scopus 로고    scopus 로고
    • Intravitreal triamcinolone acetonide versus bevacizumab therapy for macular edema associated with branch retinal vein occlusion
    • Byun YJ, Roh MI, Lee SC, Koh HJ. Intravitreal triamcinolone acetonide versus bevacizumab therapy for macular edema associated with branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol.
    • Graefes Arch Clin Exp Ophthalmol
    • Byun, Y.J.1    Roh, M.I.2    Lee, S.C.3    Koh, H.J.4
  • 27
    • 77949268295 scopus 로고    scopus 로고
    • Combined treatment of intravitreal bevacizumab and intravitreal triamcinolone in patients with retinal vein occlusion: 6 months of follow-up
    • Ehrlich R, Ciulla TA, Moss AM, Harris A. Combined treatment of intravitreal bevacizumab and intravitreal triamcinolone in patients with retinal vein occlusion: 6 months of follow-up. Graefes Arch Clin Exp Ophthalmol 2010;248:375-380.
    • (2010) Graefes Arch Clin Exp Ophthalmol , vol.248 , pp. 375-380
    • Ehrlich, R.1    Ciulla, T.A.2    Moss, A.M.3    Harris, A.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.